NCT03082898View on ClinicalTrials.gov

Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Clinical Setting (SC140121 Study 1 and 2)

NACompletedINTERVENTIONAL
Enrollment

41

Participants

Timeline

Start Date

November 15, 2016

Primary Completion Date

June 1, 2020

Study Completion Date

June 1, 2020

Conditions
Spinal Cord Injury
Interventions
DEVICE

Indego Exoskeleton

Regular dosing of Indego Exoskeleton walking.

Trial Locations (3)

37212

Vanderbilt, Nashville

55905

Mayo Clinic, Rochester

FL 33637-1022

Tampa VA, Tampa

All Listed Sponsors
lead

Vanderbilt University

OTHER

NCT03082898 - Mobility and Therapeutic Benefits Resulting From Exoskeleton Use in a Clinical Setting (SC140121 Study 1 and 2) | Biotech Hunter | Biotech Hunter